Table 2 Commercial tests for clinical analysis of breast cancer
From: The pleiotropic roles of non-hormonal receptor basigin and regulatory microRNAs in breast cancer
Test | Analytes | Detection Method | Use | References |
|---|---|---|---|---|
PAM50 gene panel | 50 gene panel | Microarray, qRT-PCR | BC Prognosis 4 subtypes classification | |
Prosigna | PAM50 panel | Nanostring Array | Risk of Recurrence | |
Blueprint | 80 gene panel | Microarray | Selecting chemotherapy or endocrine therapy | |
Oncotype DX | 16 prognostic +5 reference genes | qRT-PCR | Risk of Recurrence | |
MammaPrint | 70 genes | Microarray | Administration of chemotherapy |
